Skip to content

Influence of metabolic factors and treatment on the occurrence and development of neurosyphilis

Influence of metabolic factors and treatment on the occurrence and development of neurosyphilis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098736
Enrollment
Unknown
Registered
2025-03-13
Start date
2023-01-01
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurosyphilis

Interventions

Observation group:None

Sponsors

Shanghai Skin Disease Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1. Diagnostic criteria for syphilis infection: confirmed by TPPA positive, seroreactive RPR positive. At the same time, according to national standards, the disease stages of syphilis are classified according to clinical examination and medical history, and syphilis with an unknown incubation period is defined as late latent syphilis. 2. Diagnostic criteria for neurosyphilis: (1) any stage of syphilis; (2) positive for reactive or non-reactive CSF-VDRL; (3) Elevated cerebrospinal fluid protein (>50 mg/dL) or white blood cell count (>10 cells/µL) without other known abnormal causes. 3. Standardized treatment standards: Those who are treated according to the national treatment guidelines are standardized treatments. (1) For syphilis patients without neurological impairment, intramuscular benzathine penicillin G at 2.4 million u per week for 2 consecutive weeks (early syphilis) or 3 weeks (late syphilis), or (2) intravenous crystalloid penicillin G every 4 hours for 14 days, or (3) ceftriaxone 2.0 g/d intravenous infusion for 15 days as an alternative for penicillin-allergic patients.

Exclusion criteria

Exclusion criteria: Exclude children and pregnant women.

Design outcomes

Primary

MeasureTime frame
Blood glucose;Blood fat;Blood pressure;

Countries

China

Contacts

Public ContactFuquan Long

Shanghai Skin Disease Hospital

longfuquan777@163.com+86 180 1733 6808

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026